Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.
Standard
Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics. / Bacher, Ulrike; Kern, W; Alpermann, T; Schnittger, S; Kohlmann, A; Klein, H-U; Dugas, M; Haferlach, C; Haferlach, T.
in: LEUKEMIA, Jahrgang 25, Nr. 8, 8, 2011, S. 1361-1364.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Prognosis in patients with MDS or AML and bone marrow blasts between 10% and 30% is not associated with blast counts but depends on cytogenetic and molecular genetic characteristics.
AU - Bacher, Ulrike
AU - Kern, W
AU - Alpermann, T
AU - Schnittger, S
AU - Kohlmann, A
AU - Klein, H-U
AU - Dugas, M
AU - Haferlach, C
AU - Haferlach, T
PY - 2011
Y1 - 2011
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Aged, 80 and over
KW - Prognosis
KW - Nuclear Proteins/genetics
KW - Blast Crisis/pathology
KW - Cytogenetics
KW - Leukemia, Myeloid, Acute/genetics/mortality/pathology
KW - Myelodysplastic Syndromes/genetics/mortality/pathology
KW - Adult
KW - Humans
KW - Male
KW - Aged
KW - Female
KW - Middle Aged
KW - Aged, 80 and over
KW - Prognosis
KW - Nuclear Proteins/genetics
KW - Blast Crisis/pathology
KW - Cytogenetics
KW - Leukemia, Myeloid, Acute/genetics/mortality/pathology
KW - Myelodysplastic Syndromes/genetics/mortality/pathology
M3 - SCORING: Journal article
VL - 25
SP - 1361
EP - 1364
JO - LEUKEMIA
JF - LEUKEMIA
SN - 0887-6924
IS - 8
M1 - 8
ER -